About Us
K-Natural Product New Drug Development Platform (HAT.i) Green Bio Company
Ewhaon is a green bio company that develops natural product new drugs and biomaterials using the patented HAT.i® platform technology of Rubus coreanus oil extracted from domestic natural product Rubus coreanus
British Heart Foundation
“Don’t take vitamin supplements, take natural vitamins through the heart”
“Don’t take vitamin supplements, take natural vitamins through the heart”
Why Rubus coreanus?
Safe and excellent pharmacological effects without side effects, used for 2,000 years
- Anti-inflammatory, anti-allergic action
- Antiviral action
- Hormone regulating effect, nourishing and tonic effect
Source: Dongmyeongsa Editorial Department Author (Article) / Pharmacy/Science
- Pain relief, anti-inflammatory action
- Hepatoprotective action, memory enhancement action
- Natural tonic that restores sperm count and motility
Source: Oriental Pharmacology Textbook Compilation Committee (Editor) / Oriental Pharmacology, 5th edition
Oriental medical efficacy
- (Kidney health) It is mainly used when men have little stamina or women do not have children.
- (Improvement of sexual function) It makes men’s genitals firm and large.
- (Liver, eye health) It provides nutrition to the liver and brightens the eyes.
- (Immunity enhancement, anti-obesity) It replenishes energy and makes the body lighter.
- (Anti-aging) It prevents hair from turning gray.
- (Skin health) It improves complexion.
Source: Shin Jeon-hwi, Shin Yong-wook (authors) / Donguibogam in Herbal Medicine Pictures (Banyangjang)
Chairman
Dr. Hyun-soo Lee
- Current, Chairman of SFU Seohyun Foundation
- Former President of Celltrion
- IR52 Jang Yeong-sil Award for development of anticancer drug Taxol in 1999, Bio Industry Grand Prize in 2000
- Former Vice President and Research Director of Samyang Genex
(Development of noteworthy natural product-derived anticancer drug Taxol) - Doctorate in Food Engineering, College of Agriculture and Life Sciences, Seoul National University
CMO
Hyun-soo Nam
- R&D Planning Marketing Director
- Former CEO of Jake Clean Barley Co., Ltd.
- Citibank Asset Management Specialist
- UK Mackies Asia CEO
- E-Land Group Marketing Team Leader
- Korea University College of Agriculture, Food Resources Department
CTO
Dr. In-hwa Jeong
- EWHAON Natural Product New Drug Licensing
- CEO of Sungwoon Pharmacopia
- Establishment of Indonesia KFSP JV
- Former CJ Technology Team Leader
- Former Researcher at KAIST
- Ph.D. in Chemistry, Korea University
CGO
JASON Lee
- EWHAON Global Marketing Director
- Former Managing Director of Biohouse Co., Ltd.
- Former Managing Director of Prodigen Co., Ltd.
- CEO of Logos Resources Co., Ltd.
- UC Irvine USA. Biological Science
CFO
Jong-ho Park
- Former Vice President of Yubiologics, a listed company
- Former Investment Team Leader of Woori Technology Investment
- Former Senior Researcher and Investment Team Leader of Amorepacific
- Doctorate in Mechanical Engineering, Department of Biology, Yonsei University
Patented Technology Patent Information
100% Bokbunja Seed Oil | R.Coreanus oil
HAT Inhibition Bokbunja Seed Oil Composition Patent
(Patent No. 10-1024399)
(Patent No. 10-1024399)
The inventors of the present invention have been conducting a screening for histone acetyltransferase activity inhibition ability targeting about 500 kinds of food and medicinal plants that have been used for a long time in order to secure safety and reduce clinical risks of substances required for the development of functional foods, foods, and medicines.
They have proven that the invented Bokbunja extract composition can be used to effectively prevent or treat various diseases such as brain diseases, obesity, diabetes, and cancer mediated by histone acetyltransferase activity.
They have proven that the invented Bokbunja extract composition can be used to effectively prevent or treat various diseases such as brain diseases, obesity, diabetes, and cancer mediated by histone acetyltransferase activity.
Patent Evaluation Summary Information
Patent material technology evaluation grade AAA
 |
As of the evaluation reference date (2024-08-12), this patent is equivalent to 0.8% of the total patent grade, and was finally evaluated as AAA grade. |
|
||||||||||||||||||||
|
||||||||||||||||||||||
